In response to the continued spread of COVID-19, the staff of the Division of Corporation Finance (the "Staff") of the Securities and Exchange Commission (the "SEC") has provided non-binding guidance to assist public companies in disclosing COVID-19 related risks and effects in their reporting. Additionally, the SEC has further extended filing periods and provided other relief measures for certain public company obligations under the federal securities laws.

SEC Staff Issues COVID-19 Disclosure Guidance and SEC Further Extends Certain Filing Deadlines.pdf

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.